Behçet Disease
📧 Sign up to get email alerts when something new happens for Behçet Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) [Phase 3]
Phase 3 trial comparing interferon alfa-2a versus cyclosporin A in severe ocular Behçet's disease (panuveitis) has completed.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease [Phase 1, Phase 2]
A phase 1/2 study of XOMA 052 in familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and Behçet's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Anakinra for Behcet s Disease [Phase 1, Phase 2]
A phase 1/2 clinical trial of anakinra for Behçet's disease has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions [Phase 3]
Phase 3 clinical trial of TA-650 for Behçet's disease with special lesions has completed, with results posted in December 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Efficacy of Humira in Behcet Patients With Arthritis [Phase 3]
A Phase 3 trial evaluating Humira (adalimumab) for efficacy in Behçet disease with arthritis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Tocilizumab for the Treatment of Behcet's Syndrome [Phase 2]
A Phase 2 trial evaluating tocilizumab for Behçet's disease was terminated early. Results were posted on 2016-06-02.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Impact of Vasculitis on Employment and Income
This completed clinical trial update examines how vasculitis and its subtypes impact employment and income for patients.
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis [Phase 3]
Phase 3 study of gevokizumab for Behçet's disease–associated uveitis has been terminated, with the trial not proceeding to completion.
-
FDA approval · 2015-12-21FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for OTEZLA (apremilast) from Amgen that updated its labeling.
-
FDA approval · 2015-12-17FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for COLCRYS (colchicine) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating intravitreal infliximab for refractory uveitis in Behçet's disease, assessing safety and eff…
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Stem Cell Transplantation in Ocular Lesions of Behcet's Disease [Phase 1]
Phase 1 clinical trial evaluating stem cell transplantation for ocular lesions in Behçet's disease, including retinitis; the study status is…
-
FDA label_change · 2015-04-27FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
FDA announces that Amgen's supplemental application for OTEZLA (apremilast) has been approved, updating the product labeling accordingly.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease [Phase 2]
Phase 2 trial assessing efficacy and safety of apremilast (CC-10004) for Behçet disease has completed with results posted.
-
CLINICAL_TRIALS research · 2014-07-15Clinical Trial Update: Educational Needs of Patients With Systemic Vasculitis
The document reports on a completed clinical trial evaluating the educational needs and resources for patients with systemic vasculitis.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Vasculitis Illness Perception (VIP) Study
The Vasculitis Illness Perception (VIP) study has completed. The update lists several vasculitis conditions studied, including granulomatosi…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Reproductive Health in Men and Women With Vasculitis
A completed clinical trial evaluating reproductive health in men and women with various forms of vasculitis.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE
The completed study investigates mevalonate kinase gene mutations and their clinical correlations in Behçet's disease.
-
CLINICAL_TRIALS research · 2012-11-02Clinical Trial Update: The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease
Completed clinical trial update examining how serum angiogenin, basic fibroblast growth factor (bFGF), and vascular endothelial growth facto…
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Behçet's Disease and Eosinophil Cationic Protein
Completed clinical trial evaluating eosinophil cationic protein in Behçet's disease conducted at Cukurova University.
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease [Phase 4]
Phase 4 clinical study evaluating the efficacy of methylprednisolone for ocular involvement in Behçet's disease. The sponsor is Tehran Unive…
-
CLINICAL_TRIALS research · 2010-11-22Clinical Trial Update: Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease [NA]
This document provides a clinical trial update for a single-blind controlled study of etanercept in ocular manifestations of Behçet's diseas…
-
CLINICAL_TRIALS trial_result · 2009-06-16Clinical Trial Update: Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease [Phase 2]
Phase 2 trial evaluating low-dose interferon alpha for oral ulcers in Behçet's disease has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease [Phase 2]
Phase 2 trial evaluating Rituximab for severe ocular manifestations of Behçet's disease has completed.